nach oben

European Archives of Oto-Rhino-Laryngology

Erschienen in:

25.10.2018 | Head & Neck

Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas

verfasst von: Valéria Souza Freitas, Jean Nunes dos Santos, Pedro Paulo de Andrade Santos, Cassiano Francisco Weege Nonaka, Leão Pereira Pinto, Lélia Batista de Souza

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare the immunohistochemical expression of matrix metalloproteinases-2, -7, -9 and -26 and tissue inhibitors of metalloproteinases-1 and -2 in pleomorphic adenomas and adenoid cystic carcinomas of the minor salivary glands.

Methods

Twenty cases of pleomorphic adenomas and 20 cases of adenoid cystic carcinomas were evaluated for the immunohistochemical expression of matrix metalloproteinases-2, -7, -9, and -26 and tissue inhibitors-1 and -2 in tumor parenchyma.

Results

Most pleomorphic adenomas and adenoid cystic carcinomas showed high expression of matrix metalloproteinases and tissue inhibitors, predominantly located in the tumor cells. There was no statistically significant difference in the expression of the metalloproteinases-2 (p = 0.359), -7 (p = 0.081), and -26 (p = 0 553), as well as the tissue inhibitors-1 (p = 0.657), and -2 (p = 0.248) between the parenchyma of the studied tumors. Only matrix metalloproteinase-9 showed a significant difference in expression between the two tumors, with adenoid cystic carcinoma showing a more intense staining for this gelatinase (p = 0.041).

Conclusions

The expression of the studied metalloproteinases suggests the involvement of these enzymes in the tissue remodeling process in pleomorphic adenomas and adenoid cystic carcinomas, but only MMP-9, significantly expressed in the adenoid cystic carcinomas, appears to be involved in the process of invasiveness and more aggressive behavior of these tumors. Additionally, results point that TIMPs-1 and -2 may have more complex functions besides metalloproteinase inhibition, which may be related to the pathogenesis and biological behavior of salivary gland tumors.

Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World health organization classification of tumors: pathology & genetics—head and neck tumors, 3 edn. IARC Press, Lyon

Sung MW, Kim KH, Kim JW et al (2003) Clinicopathologic predictors and impact of distant metastasis from adenoid cystic carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 129(11):1193–1197. https://doi.org/10.1001/archotol.129.11.1193.CrossRefPubMed

El-Naggar AK et al (2017) WHO classification of head and neck tumors, 4 edn. IARC Press, Lyon

Bobbio A, Copelli C, Ampollini L et al (2008) Lung metastasis resection of adenoid cystic carcinoma of salivary glands. Eur J Cardiothorac Surg 33(5):790–793. https://doi.org/10.1016/j.ejcts.2007.12.057 CrossRefPubMed

Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69(3):562–573. https://doi.org/10.1016/j.cardiores.2005.12.002 CrossRefPubMed

Barros SSLV, Henriques ÁCG, Pereira KMA et al (2011) Immunohistochemical expression of matrix metalloproteinases in squamous cell carcinoma of the tongue and lower lip. Arch Oral Biol 56(8):752–760. https://doi.org/10.1016/j.archoralbio.2010.11.022 CrossRefPubMed

Souza Freitas V, de Andrade Santos PP, Almeida Freitas RD et al (2011) Mast cells and matrix metalloproteinase 9 expression in actinic cheilitis and lip squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 112(3):342–348. https://doi.org/10.1016/j.tripleo.2011.02.032.CrossRefPubMed

Kayano K, Shimada T, Shinomiya T et al (2004) Activation of pro-MMP-2 mediated by MT1-MMP in human salivary gland carcinomas: possible regulation of pro-MMP-2 activation by TIMP-2. J Pathol 202(4):403–411. https://doi.org/10.1002/path.1541 CrossRefPubMed

Wang Y, Irie T, Aida T, Tachikawa T (2005) Expression of TIMP-1 and -2 in different growth patterns of adenoid cystic carcinoma. Oral Oncol 41(8):821–827. https://doi.org/10.1016/j.oraloncology.2005.04.009 CrossRefPubMed

10.

Nagel H, Laskawi R, Wahlers A, Hemmerlein B (2004) Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland. Histopathology 44(3):222–231CrossRef

11.

Hu JA, Xu JY, Li YN et al (2005) Expression of MMP-2 and E-CD in salivary mucoepidermoid carcinoma and its correlation with infiltration, metastasis and prognosis. Zhejiang Da Xue Xue Bao Yi Xue Ban 34(5):421–426PubMed

12.

Chen Y, Tian K, Geng N et al (2005) The expression of matrix metalloproteinases and their tissue inhibitors in pleomorphic adenoma]. Zhonghua Kou Qiang Yi Xue Za Zhi 40(1):58–61PubMed

13.

Lipari L, Mauro A, Gallina S, Tortorici S, Buscemi M, Tete S, Gerbino A (2012) Expression of gelatinases (Mmp-2, Mmp-9) and cyclooxygenases (Cox1, Cox-2) in some benign salivary gland tumors. Int J Immunopathol Pharmacol 25(1):107–115. https://doi.org/10.1177/039463201202500113 CrossRefPubMed

14.

Mardani M, Andisheh-Tadbir A, Khademi B et al (2014) Serum level of matrix metalloproteinase-9 in patients with salivary gland tumor. J Dent Shiraz Univ Med Sci 15(4):199–203

15.

Tang YL, Liu X, Gao SY et al (2015) WIP1 stimulates migration and invasion of salivary adenoid cystic carcinoma by inducing MMP-9 and VEGF-C. Oncotarget 6(11):9031–9044. https://doi.org/10.18632/oncotarget.3320 CrossRefPubMedPubMedCentral

16.

Kolude B, Akinyele A, Ahmed L et al (2015) Stoichiometric expression of MMP-2/TIMP-2 in benign and malignant tumours of the salivary gland. Tumor Biol 36:2351–2357. https://doi.org/10.1007/s13277-014-2842-8 CrossRef

17.

Zhao L, Jiang L, Du P et al (2016) Expression of SKA1 and MMP-9 in primary salivary adenoid cystic carcinoma: Correlation with tumor progression and patient prognosis. Acta Otolaryngol 136(6):575–579. https://doi.org/10.3109/00016489.2016.1142117 CrossRefPubMed

18.

Luukkaa H, Klemi P, Hirsimaki P et al (2010) Matrix metalloproteinase (MMP)-7 in salivary gland cancer. Acta Oncol 49(1):85–90. https://doi.org/10.3109/02841860903287197 (a) CrossRefPubMed

19.

Daa T, Kashima K, Kondo Y et al (2008) Aberrant methylation in promoter regions of cyclin-dependent kinase inhibitor genes in adenoid cystic carcinoma of the salivary gland. APMIS 116(1):21–26. https://doi.org/10.1111/j.1600-0463.2008.00773.x CrossRefPubMed

20.

Polette M, Nawrocki-Raby B, Gilles C et al (2004) Tumour invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 49(3):179–186. https://doi.org/10.1016/j.critrevonc.2003.10.008 CrossRefPubMed

21.

Li M, Yamamoto H, Adachi Y et al (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231(1):20–27CrossRef

22.

Zhang CY, Mao L, Li L et al (2007) Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma. Cancer 110(1):87–95. https://doi.org/10.1002/cncr.22758 CrossRefPubMed

23.

Wang R, Geng N, Zhou Y et al (2015) Aberrant Wnt-1/beta-catenin signaling and WIF-1 deficiency are important events which promote tumor cell invasion and metastasis in salivary gland adenoid cystic carcinoma. Bio-Med Mater Eng 26(1): S2145-153. https://doi.org/10.3233/BME-151520 CrossRef

24.

Bourboulia D, Stetler-Stevenson WG (2010) Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 20(3):161–168. https://doi.org/10.1016/j.semcancer.2010.05.002 CrossRefPubMedPubMedCentral

25.

Tian K, Chen Y, Geng N et al (2005) Relationship of the disturbed balance between matrix metalloproteinases and their tissue inhibitors and the invasion of malignant salivary gland tumours. Hua xi kou qiang yi xue za zhi 23(4):273–276PubMed

26.

Luukkaa H, Klemi P, Leivo I et al (2010) Expression of matrix metalloproteinase-1, -7, -9, -13, Ki-67, and HER-2 in epithelial-myoepithelial salivary gland cancer. Head Neck 32(8):1019–1027. https://doi.org/10.1002/hed.21277(b) CrossRefPubMed

27.

Verma RP, Hansch C (2007) Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg Med Chem 15(6):2223–2268. https://doi.org/10.1016/j.bmc.2007.01.011 CrossRefPubMed

28.

Monaghan H, MacWhinnie N, Williams AR (2007) The role of matrix metalloproteinases-2, -7 and -9 and beta-catenin in high grade endometrial carcinoma. Histopathology 50(3):348–357. https://doi.org/10.1111/j.1365-2559.2007.02612.x CrossRefPubMed

29.

Kerkela E, Saarialho-Kere U (2003) Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol 12(2):109–125CrossRef

30.

Kuula H, Salo T, Pirila E et al (2008) Human beta-defensin-1 and -2 and matrix metalloproteinase-25 and -26 expression in chronic and aggressive periodontitis and in peri-implantitis. Arch Oral Biol 53(2):175–186. https://doi.org/10.1016/j.archoralbio.2007.09.010 CrossRefPubMed

31.

Uria JA, Lopez-Otin C (2000) Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res 60(17):4745–4751PubMed

32.

Luukkaa H, Klemi P, Hirsimaki P et al (2008) Matrix metalloproteinase (MMP)-1, -9 and -13 as prognostic factors in salivary gland cancer. Acta Otolaryngol 128(4):482–490. https://doi.org/10.1080/00016480801922895 CrossRefPubMed

33.

Zhang X, Wang Y, Yamamoto G, Tachikawa T (2009) Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1 and TIMP-2 in the epithelium and stroma of salivary gland pleomorphic adenomas. Histopathology 55(3):250–260. https://doi.org/10.1111/j.1365-2559.2009.03355.x CrossRefPubMed

34.

Raitz R, Martins MD, Araujo VC (2003) A study of the extracellular matrix in salivary gland tumors. J Oral Pathol Med 32(5):290–296CrossRef

35.

Bento PM, Freitas RA, Pinto LP, Souza LB (2006) Tenascin and fibronectin in pleomorphic adenoma of the salivary gland. J Appl Oral Sci 14(3):198–202CrossRef

36.

de Vicente JC, Lequerica-Fernandez P, Lopez-Arranz JS et al (2008) Expression of matrix metalloproteinase-9 in high-grade salivary gland carcinomas is associated with their metastatic potential. Laryngoscope 118(2):247–251. https://doi.org/10.1097/MLG.0b013e318158f754 CrossRefPubMed

Titel: Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas
verfasst von: Valéria Souza Freitas
Jean Nunes dos Santos
Pedro Paulo de Andrade Santos
Cassiano Francisco Weege Nonaka
Leão Pereira Pinto
Lélia Batista de Souza
Publikationsdatum: 25.10.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: European Archives of Oto-Rhino-Laryngology / Ausgabe 12/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-018-5176-0

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Expression of matrix metalloproteinases (MMPs-2, -7, -9, and -26) and tissue inhibitors of metalloproteinases (TIMPs-1 and -2) in pleomorphic adenomas and adenoid cystic carcinomas